Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis
Clinical trial NCT03107611 · COMPLETED
Trial details
- NCT number
- NCT03107611
- Sponsor
- Mylan Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-29
- Primary completion
- 2017-05-15
- Enrollment
- 654
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.